Management of blood pressure in heart failure

被引:41
作者
Pinho-Gomes, Ana Catarina [1 ,2 ]
Rahimi, Kazem [1 ,2 ]
机构
[1] Univ Oxford, George Inst Global Hlth, Oxford OX1 2JD, England
[2] Univ Oxford, Oxford Martin Sch, Deep Med, Oxford, England
关键词
VENTRICULAR EJECTION FRACTION; PULSE-WAVE VELOCITY; MORTALITY; MORBIDITY; OUTCOMES; PROGNOSIS; EFFICACY; INSIGHTS; BLOCKER; IMPACT;
D O I
10.1136/heartjnl-2018-314438
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Hypertension is a common comorbidity in patients with heart failure and most drugs that have demonstrated to improve prognosis in this population have the potential to reduce blood pressure. Nonetheless, the relationship between blood pressure and clinical outcomes and the relevance of blood pressure reduction in heart failure remains unclear. This narrative review summarises the evidence currently available to guide blood pressure treatment in this patient group and highlights key questions for further research. In patients with heart failure with reduced ejection fraction, guidelines consensually recommend treating hypertension with drugs that have compelling indications in heart failure, with a target blood pressure of 130/80 mmHg. In patients with heart failure with preserved ejection fraction, guidelines acknowledge that the optimal treatment strategy remains unclear and thus recommend adopting a similar treatment strategy to patients with reduced ejection fraction. In any case, low blood pressure should not deter uptitration of drugs otherwise indicated to improve prognosis in heart failure, provided that patients tolerate drugs without adverse events. In the absence of evidence for modification of treatment efficacy and safety by baseline blood pressure, it is likely that treatment may actually lead to higher absolute risk reduction in patients with the lowest blood pressure. Special considerations and treatment adjustments are needed in the elderly as well as in patients with diabetes, chronic kidney disease and atrial fibrillation. More evidence is needed on blood pressure management in patients with heart failure in general, in whom the increasing burden of multimorbidity adds further complexity to treatment.
引用
收藏
页码:589 / 595
页数:7
相关论文
共 30 条
  • [1] Agodoa L, 2007, J HYPERTENS, V25, P951
  • [2] Impact of Noncardiac Comorbidities on Morbidity and Mortality in a Predominantly Male Population With Heart Failure and Preserved Versus Reduced Ejection Fraction
    Ather, Sameer
    Chan, Wenyaw
    Bozkurt, Biykem
    Aguilar, David
    Ramasubbu, Kumudha
    Zachariah, Amit A.
    Wehrens, Xander H. T.
    Deswal, Anita
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 59 (11) : 998 - 1005
  • [3] Association of systolic blood pressure with mortality in patients with heart failure with reduced ejection fraction: A complex relationship
    Ather, Sameer
    Chan, Wenyaw
    Chillar, Annirudha
    Aguilar, David
    Pritchett, Allison M.
    Ramasubbu, Kumudha
    Wehrens, Xander H. T.
    Deswal, Anita
    Bozkurt, Biykem
    [J]. AMERICAN HEART JOURNAL, 2011, 161 (03) : 567 - 573
  • [4] Trials on the Effect of Cardiac Resynchronization on Arterial Blood Pressure in Patients With Heart Failure
    Ather, Sameer
    Bangalore, Sripal
    Vemuri, Srinath
    Cao, Long B.
    Bozkurt, Biykem
    Messerli, Franz H.
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2011, 107 (04) : 561 - 568
  • [5] Effect of mineralocorticoid antagonists on blood pressure lowering: overview and meta-analysis of randomized controlled trials in hypertension
    Bazoukis, George
    Thomopoulos, Costas
    Tsioufis, Costas
    [J]. JOURNAL OF HYPERTENSION, 2018, 36 (05) : 987 - 994
  • [6] Is there a blood pressure lowering effect of MRAs in heart failure? An overview and meta-analysis
    Bazoukis, George
    Thomopoulos, Costas
    Tse, Gary
    Tsioufis, Costas
    [J]. HEART FAILURE REVIEWS, 2018, 23 (04) : 547 - 553
  • [7] Systolic blood pressure, cardiovascular outcomes and efficacy and safety of sacubitril/valsartan (LCZ696) in patients with chronic heart failure and reduced ejection fraction: results from PARADIGM-HF
    Bohm, Michael
    Young, Robin
    Jhund, Pardeep S.
    Solomon, Scott D.
    Gong, Jianjian
    Lefkowitz, Martin P.
    Rizkala, Adel R.
    Rouleau, Jean L.
    Shi, VictorC.
    Swedberg, Karl
    Zile, Michael R.
    Packer, Milton
    McMurray, John J. V.
    [J]. EUROPEAN HEART JOURNAL, 2017, 38 (15) : 1132 - 1143
  • [8] The EuroHeart Failure survey programme - a survey on the quality of care among patients with heart failure in Europe - Part 1: patient characteristics and diagnosis
    Cleland, JGF
    Swedberg, K
    Follath, F
    Komajda, M
    Cohen-Solal, A
    Aguilar, JC
    Dietz, R
    Gavazzi, A
    Hobbs, R
    Korewicki, J
    Madeira, HC
    Moiseyev, VS
    Preda, I
    van Gilst, WH
    Widimsky, J
    Freemantle, N
    Eastaugh, J
    Mason, J
    [J]. EUROPEAN HEART JOURNAL, 2003, 24 (05) : 442 - 463
  • [9] EFFECT OF VASODILATOR THERAPY ON MORTALITY IN CHRONIC CONGESTIVE-HEART-FAILURE - RESULTS OF A VETERANS-ADMINISTRATION COOPERATIVE STUDY
    COHN, JN
    ARCHIBALD, DG
    ZIESCHE, S
    FRANCIOSA, JA
    HARSTON, WE
    TRISTANI, FE
    DUNKMAN, WB
    JACOBS, W
    FRANCIS, GS
    FLOHR, KH
    GOLDMAN, S
    COBB, FR
    SHAH, PM
    SAUNDERS, R
    FLETCHER, RD
    LOEB, HS
    HUGHES, VC
    BAKER, B
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1986, 314 (24) : 1547 - 1552
  • [10] Impact of Baseline Systolic Blood Pressure on Long-Term Outcomes in Patients With Advanced Chronic Systolic Heart Failure (Insights from the BEST Trial)
    Desai, Ravi V.
    Banach, Maciej
    Ahmed, Mustafa I.
    Mujib, Marjan
    Aban, Inmaculada
    Love, Thomas E.
    White, Michel
    Fonarow, Gregg
    Deedwania, Prakash
    Aronow, Wilbert S.
    Ahmed, Ali
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2010, 106 (02) : 221 - 227